breakthroughs
The members of the Cancer Research Alliance® are at the forefront of revolutionary
research, making tremendous strides in the diagnosis, treatment and prevention of all types of cancer.
Our progressive methods allow us to deliver breakthroughs to people around the globe, and our research
will continue to improve the odds for generations to come.
Home to 9 Nobel Prize winners, CRA member centers have a
long history of pioneering research and groundbreaking achievements in cancer research.
CRA member centers were THE FIRST...
- cancer hospital and cancer research institutes in the U.S.
- to offer chemo treatments
- to achieve remission in childhood leukemia
- to identify the prostate-specific antigen (PSA) test as a mechanism to treat prostate cancer
- to introduce immediate reconstructive surgery following tumor excision
- to develop a therapy that leads to the best-reported survival for patients with post-renal-transplant lymphoma
CRA member centers PIONEERED...
- radiation medicine
- chemoprevention
- bone marrow transplants
- studies on the relationship between smoking and lung cancer
- early detection strategies, including biomarker assays and the development of tumor suppressor genes
- development of a vaccine for patients with extensive-stage small-cell lung cancer
CRA member centers DISCOVERED...
- cancer-causing oncogenes
- two genetic mutations that predict clinical outcome for leukemia patients
- human papilloma virus, the primary cause of cervical cancer
- the first FDA approved vaccine for the prevention of cervical cancer
- the site and stages of human natural killer cell development
- the role of T helper cells in controlling infection by a tumor virus
- telomeres, proteins that cap the ends of chromosomes and regulate the longevity and death of
human and animal cells when they divide
- telomerase, an enzyme that is responsible for synthesizing the telomeres and thought to be a key
to slowing age-related diseases and halting the uncontrolled growth of tumor cells
- the Philadelphia chromosome, the first genetic abnormality associated with a human cancer
- hairy cell leukemia then developed the treatment and cure: deoxycoformycin
Through your partnership, we believe that we can speed our
visionary work to save lives and end the suffering caused by cancer—not just in our communities, but
around the world.